Status:
COMPLETED
Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
COVID-19 Severe Pneumonia
Severe Pneumonia Due to Other Pathogene
Eligibility:
All Genders
18+ years
Brief Summary
SARS-COV 2 infection might be responsible for sever pneumonia. Obesity seems to be a risk factor for severe SARS-COV 2 pneumonia. Lipid metabolism alteration are described with both obesity and sepsis...
Eligibility Criteria
Inclusion
- 2 of the following criteria: Cough/ Dyspnea/ Spitting/ Thoracic pain/ Hyperthermia (\>=38 °C) Hypothermia (\< 35°C) AND new radiologic pulmonary infiltrate
- At admission or within 48 hours following hospital admission
- With 2 qSOFA criteria: MAP =\< 100 mmHg, Respiratory Rate \>= 22, Glasgow score \< 15 OR on mechanical ventilation OR under vasopressor
- Age \> 18
- affiliated to social security
Exclusion
- Pregnancy
- immunodepression
- Pathology known to cause severe lymphopenia
- hospitalisation within 3 month before inclusion AND sepsis
Key Trial Info
Start Date :
April 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 7 2020
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04435223
Start Date
April 7 2020
End Date
May 7 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000